Robert Lenz
Patrimonio netto: 571 820 $ in data 31/05/2026
Patrimonio netto: 571 820 $ in data 31/05/2026
Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/02/2025 | 309.092 ( 0,17% ) | 571 820 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Direttore/Membro del Consiglio | 22/08/2025 |
| LB PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 06/03/2026 |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Producer Manufacturing |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale